Phase 2 Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are scheduled to receive TACE (a procedure that delivers treatment directly to a liver tumour) for a liver tumour
- People who are at least 18 years old
- People who are in a stable medical condition
- Women of childbearing age who have a negative pregnancy test result
- People who have given their signed agreement to take part in the study
Who may not be able to join:
- People who are medically unstable, seriously or terminally ill, or whose medical condition is difficult to predict
- People who are known to have sensitivities or allergic reactions to the ingredients in Lumason (a contrast agent used in ultrasound imaging)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 215-503-5188
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recurrence; Sensitivity; Specificity; Positive predictive value; Negative predictive value; False discovery rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.